Identification of non-tuberculous mycobacteria: utility of the GenoType Mycobacterium CM/AS assay compared with HPLC and 16S rRNA gene sequencing

1 Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, Australia 2 Western Clinical School, University of Sydney, Sydney, Australia Correspondence Gwendolyn L. Gilbert l.gilbert{at}usyd.edu.au Received October 22, 2008 Acce...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical microbiology Vol. 58; no. 7; pp. 900 - 904
Main Authors Lee, Andie S, Jelfs, Peter, Sintchenko, Vitali, Gilbert, Gwendolyn L
Format Journal Article
LanguageEnglish
Published Reading Soc General Microbiol 01.07.2009
Society for General Microbiology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, Australia 2 Western Clinical School, University of Sydney, Sydney, Australia Correspondence Gwendolyn L. Gilbert l.gilbert{at}usyd.edu.au Received October 22, 2008 Accepted March 27, 2009 Non-tuberculous mycobacteria (NTM) causing clinical disease have become increasingly common and more diverse. A new reverse line probe assay, GenoType Mycobacterium CM/AS (Hain Lifescience), was evaluated for identification of a broad range of NTM. It was compared with phenotypic (HPLC) and molecular (DNA probes, in-house real-time multiplex species-specific PCR, 16S rRNA gene PCR and sequencing) identification techniques, which together provided the reference ‘gold standard’. A total of 131 clinical isolates belonging to 31 Mycobacterium species and 19 controls, including 5 non- Mycobacterium species, was used. Concordant results between the GenoType Mycobacterium assay and the reference identification were obtained in 119/131 clinical isolates (90.8 %). Identification of Mycobacterium abscessus and Mycobacterium lentiflavum by the assay was problematic. The GenoType Mycobacterium assay enables rapid identification of a broad range of potentially clinically significant Mycobacterium species, but some species require further testing to differentiate or confirm ambiguous results. Present address: Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2615
1473-5644
DOI:10.1099/jmm.0.007484-0